Nicotine

Saturday, 13 April 2002

Organizer

L. Galanti (Yvoir, Belgium)  

Sponsor

GlaxoSmithKline  

Tobacco addiction: from nicotine receptorsto smoking cessation

Session I

 
Abstract no
Chairs J. Prignot (Brussels, Belgium)
L. Galanti (Yvoir, Belgium)
 
11.00 – 11.15 Utilization of a structured record in the smoking cessation process
J. Dumont (Brussels, Belgium)
 
11.15 – 11.45 In utero exposure to heavy maternal smoking induces nicotine withdrawal symptoms in neonates
V. Godding
, C. Bonnier, L. Fiasse, M. Michel, E. Longueville, and L. Galanti (Brussels, Belgium)
150
11.45 – 12.15 Anxiety, Nesbit’s paradox and smoking
R. Molimard (Paris, France)
 
12.15 – 12.30 Nicotinic receptors involved in bleomycin induced apoptosis
D. Gimonet, P. Coninx, F. Antonicelli, B. Haye, and F. Liautaud-Roger (Reims, France)
148
12.30 – 13.00 discussion and end of session  
13.00 – 14.00 lunch and poster viewing  

Session II

Saturday, 13 April 2002
Chairs P. Bartsch (Liège, Belgium)V. Godding (Brussels, Belgium)
Abstract no
14.00 – 14.30 Tobacco addiction: from nicotine receptors to smoking cessation
K. Fagerström (Helsingborg, Sweden)
 
14.30 – 15.00  Neuronal nicotinic receptors : from structure to function
J. Le Houezec (Paris, France)
 
15.00 – 15.30 Smoking effects on brain functional imaging
T. Vander Borght (Yvoir, Belgium)
149
15.30 – 16.00 coffee break  
16.00 – 16.30 Nicotine and bupropion, the unique pharmacological approach of  smoking cessation?
P. Bartsch (Liège, Belgium)
 
16.30 – 17.00 Smoking reduction – Harm reduction?
J. Prignot (Brussels, Belgium)
 
17.00 – 17.30 discussion and end of session  
17.30 end of workshop 17  
     

Workshop 17 Posters                                                 


Abstract no
Tobacco withdrawal looked as a mourning process
J. Coulon, and A. Grivegnée (Brussels, Belgium.)
151